Correlation Between Pharmaceuticals Ultrasector and Precious Metals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Precious Metals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Precious Metals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Precious Metals Ultrasector, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Precious Metals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Precious Metals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Precious Metals.

Diversification Opportunities for Pharmaceuticals Ultrasector and Precious Metals

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Pharmaceuticals and Precious is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Precious Metals Ultrasector in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precious Metals Ultr and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Precious Metals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precious Metals Ultr has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Precious Metals go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Precious Metals

Assuming the 90 days horizon Pharmaceuticals Ultrasector is expected to generate 2.31 times less return on investment than Precious Metals. But when comparing it to its historical volatility, Pharmaceuticals Ultrasector Profund is 1.77 times less risky than Precious Metals. It trades about 0.02 of its potential returns per unit of risk. Precious Metals Ultrasector is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  3,914  in Precious Metals Ultrasector on September 12, 2024 and sell it today you would earn a total of  586.00  from holding Precious Metals Ultrasector or generate 14.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pharmaceuticals Ultrasector Pr  vs.  Precious Metals Ultrasector

 Performance 
       Timeline  
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Precious Metals Ultr 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Precious Metals Ultrasector has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pharmaceuticals Ultrasector and Precious Metals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmaceuticals Ultrasector and Precious Metals

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Precious Metals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Precious Metals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precious Metals will offset losses from the drop in Precious Metals' long position.
The idea behind Pharmaceuticals Ultrasector Profund and Precious Metals Ultrasector pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals